Physician Assistant Program year 2024 Reported 2023–2024 Source: CMS Open Payments, 2026 publication

Sara Tsegay

Physician Assistant Memphis, TN Physician Assistant

NPI 1427729185 CMS profile 11487091

1211 Union Ave, Memphis, TN 38104

Open in the dashboard

General payments

$609

33 records reported · program years 2023–2024

Research payments

$0

Paid to them · None reported · program years 2023–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Sara Tsegay of Memphis, TN is reported in the CMS Open Payments database as having received $609 across 33 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $233 12
2023 General $376 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sara Tsegay
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Sara Tsegay were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Sara Tsegay Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $376 $167 $52–$557 $160
2024 $233 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2024
  1. Novartis Pharmaceuticals Corporation $140 6 payments
  2. Philips Electronics North America Corporation $135 9 payments
  3. Pfizer Inc. $65 4 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $63 3 payments
  5. Regeneron Healthcare Solutions, Inc. $51 2 payments
  6. AstraZeneca Pharmaceuticals LP $44 3 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $44 3 payments
  8. Daiichi Sankyo Inc. $25 1 payment
  9. Boston Scientific Corporation $24 1 payment
  10. Lexicon Pharmaceuticals, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2024
  1. Food and Beverage $609 33 payments
Products named General payments · program years 2023–2024
  1. LEQVIO $140 6 payments
  2. (5044) MCOT $60 4 payments
  3. EVKEEZA $51 2 payments
  4. (CM9) Amb Mon & Diag Und $48 3 payments
  5. FARXIGA $44 3 payments
  6. Adempas $44 3 payments
  7. JARDIANCE $43 2 payments
  8. ELIQUIS $43 3 payments
  9. NURTEC ODT $43 3 payments
  10. PAXLOVID $43 3 payments
  11. Other $117 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 46 drugs

Part D claims

3,272

Median for Physician Assistant: 241

Drug cost

$431,760

Median for Physician Assistant: $4,110

Branded share of claims

28.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 113 $144,133
Entresto Sacubitril/Valsartan Brand 68 $114,859
Farxiga Dapagliflozin Propanediol Brand 32 $37,941
Repatha Sureclick Evolocumab Brand 37 $37,404
Jardiance Empagliflozin Brand 14 $22,398
Praluent Pen Alirocumab Brand 25 $18,597
Ranolazine Er Ranolazine Brand 62 $10,874
Brilinta Ticagrelor Brand 16 $8,285
Edarbyclor Azilsartan Med/Chlorthalidone Brand 12 $4,746
Isosorbide Mononitrate Er Isosorbide Mononitrate Brand 246 $3,698

The 10 drugs with the highest cost, of 46 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$4,301

Medicare's payments for the services billed

Medicare patients

83

Average age 72

Services billed

127

59 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 70%
Ischemic heart disease 70%
Heart failure 53%
Chronic kidney disease 47%
Arthritis 41%
Atrial fibrillation 22%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVKEEZA
  • Regeneron Healthcare Solutions, Inc. $51
$51 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $45
$45 — —
INJECTAFER
  • Daiichi Sankyo Inc. $25
$25 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $20
$20 14 —
Adempas
  • Bayer HealthCare Pharmaceuticals Inc. $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

33 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record